Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Trial Evaluating the Safety and Effectiveness of the Interscope Endorotor® System for Direct Endoscopic Necrosectomy of Walled Off Pancreatic Necrosis

NCT03694210 is registered in ClinicalTrials.gov with Interscope, Inc. as lead sponsor.

NCT NCT03694210
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03694210 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Trial Evaluating the Safety and Effectiveness of the Interscope Endorotor® System for Direct Endoscopic Necrosectomy of Walled Off Pancreatic Necrosis
Lead sponsor
Interscope, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 15, 2018
Completion date
August 22, 2019
Enrollment
30 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute pancreatic necrosis, acute pancreatitis, necrotizing pancreatitis